Mark Whealy is a Neurology physician affiliated with Mayo Clinic. OpenAlex indexes 22 publications with 389 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 21 Aug 2020.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
97.3%Neuromuscular Blocker97.2%Onabotulinumtoxina100%Part B, office-administered≥83 patientsCyclooxygenase Inhibitor0.1%Ketorolac Tromethamine100%Part D<11 patientsNervous system
1.7%Calcitonin gene-related peptide (CGRP) antagonists0.4%Emgality Pen64%Aimovig Autoinjector36%Part D<11 patientsSerotonin-1b and Serotonin-1d Receptor Agonist0.3%Rizatriptan73%Sumatriptan Succinate27%Part D<11 patients+ 6 more classes in this area
Sensory organs
0.6%Corticosteroid0.6%Dexamethasone sodium phosphate100%Part B, office-administered≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
Headache The Journal of Head and Face Pain
2024 - The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans
Handbook of clinical neurology
2024 - CSF-venous fistulas associated with traumatic spinal pseudomeningoceles
Interventional Neuroradiology
2024 - Clinical and imaging outcomes of 100 patients with cerebrospinal fluid-venous fistulas treated by transvenous embolization
Journal of NeuroInterventional Surgery
2023
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”